Media coverage about Aemetis (NASDAQ:AMTX) has been trending somewhat positive this week, Accern Sentiment Analysis reports. The research firm scores the sentiment of press coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Aemetis earned a news sentiment score of 0.13 on Accern’s scale. Accern also assigned news coverage about the specialty chemicals company an impact score of 45.7587452988686 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
Several research analysts recently issued reports on AMTX shares. Zacks Investment Research upgraded shares of Aemetis from a “sell” rating to a “hold” rating in a research report on Tuesday, October 17th. B. Riley reiterated a “neutral” rating on shares of Aemetis in a research report on Wednesday, November 1st.
Aemetis (NASDAQ AMTX) opened at $0.67 on Thursday. Aemetis has a 1 year low of $0.53 and a 1 year high of $2.50. The company has a debt-to-equity ratio of -1.87, a current ratio of 0.37 and a quick ratio of 0.20.
Aemetis, Inc is an international renewable fuels and biochemicals company. The Company is focused on the production of fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products by conversion of first-generation ethanol and biodiesel plants into biorefineries.
Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.